Liabilities / Assets
41st percentile
Higher debt load relative to assets than 41% of similar nonprofits.
990 • Fiscal year 2021 • EIN 47-3601782
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
41st percentile
Higher debt load relative to assets than 41% of similar nonprofits.
Liabilities / Revenue
49th percentile
Higher debt load relative to revenue than 49% of similar nonprofits.
Net Margin
64th percentile
Higher net margin than 64% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
38th percentile
Faster asset growth than 38% of similar nonprofits.
Revenue Growth
14th percentile
Faster revenue growth than 14% of similar nonprofits.
Assets
Up$1,129,264
Up $43,212 (+4.0%) from 2020
Net Assets
Up$1,092,206
Up $94,553 (+9.5%) from 2020
Liabilities
Down$37,058
Down $51,341 (-58%) from 2020
Revenue
Down$439,215
Down $104,369 (-19%) from 2020
Expenses
Down$344,662
Down $403,290 (-54%) from 2020
Net Income
Up$94,553
Up $298,921 (+146%) from 2020
This 2021 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The registry's mission is to facilitate research and advance research to accelerate treatment development for all types of ftd, a devastating neurodegenerative disease that strikes people in the prime of life and for which, currently, there is no cure.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2021 • Form 990Summary only. Only limited summary data is available for this year.